Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | Jan 29, 2023 | ||||||||
GSM4288400 |
Primary human mammary epithelial cells
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288401 |
MCF10A cells
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288402 |
MCF7 cells - luminal type
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288403 |
MDA-MB-231 cells - triple negative
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288404 |
HS578T cells - triple negative- metaplastic
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288405 |
HS578T cells -doxorubicin resistant
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288406 |
HS578T cells - paclitaxel resistant
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288407 |
BAS cells - triple negative - metaplastic
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288408 |
BAScells -doxorubicin resistant
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4288409 |
BAS cells - paclitaxel resistant
|
RNA | 1 | Ernesto Yague | Jan 29, 2023 | ||||
GSM4387286 |
SCC-25, ctrl 6h rep1, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4387287 |
SCC-25, ctrl 6h rep2, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4387288 |
SCC-25, ctrl 6h rep3, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4387289 |
SCC-25, tuni 6h rep1, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4387290 |
SCC-25, tuni 6h rep2, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4387291 |
SCC-25, tuni 6h rep3, HTA 2.0
|
RNA | 1 | Chenzhou Wu | Jan 29, 2023 | ||||
GSM4731349 |
cancercell_treatment-naïve_replicate1
|
SRA | 1 | Cigdem Selli | Jan 29, 2023 | ||||
GSM4731350 |
cancercell_treatment-naïve_replicate2
|
SRA | 1 | Cigdem Selli | Jan 29, 2023 | ||||
GSM4731351 |
cancercell_treatment-naïve_replicate3
|
SRA | 1 | Cigdem Selli | Jan 29, 2023 | ||||
GSM4731352 |
cancercell_treatment-naïve_replicate4
|
SRA | 1 | Cigdem Selli | Jan 29, 2023 |